The pharma industry has warned that the biggest shake-up of US drug pricing regulation in decades will cripple innovation and stymie development of life-saving medicines in last-ditch lobbying aimed at blunting new legislation.
制药行业警告称，美国数十年来最大规模的药品定价监管改革，将削弱创新，阻碍救命药物的开发，这是旨在削弱新立法的最后游说。
您已阅读3%（286字），剩余97%（8294字）包含更多重要信息，订阅以继续探索完整内容，并享受更多专属服务。